Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0001567619-23-005059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-14 | 2023-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $67.81 | +23.0K | 502.9K | +5% | +$1.56M |
| DM | 2023-03-14 | 2023-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $91.64 | -23.0K | 487.9K | -5% | -$2.11M |
| DM | 2023-03-14 | 2023-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -23.0K | 149.1K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-13 | M | A | 8,000 | $67.81 | 495,856 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. |
| 2 | Common | Common Stock | 2023-03-13 | S | D | 8,000 | $90.45 | 487,856 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. |
| 3 | Common | Common Stock | 2023-03-10 | S | D | 15,000 | $92.28 | 487,856 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |
| 4 | Common | Common Stock | 2023-03-10 | M | A | 15,000 | $67.81 | 502,856 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |
| 5 | Derivative | Stock Option (Right to buy Common Stock) | 2023-03-10 | M | D | 15,000 | $0.00 | 157,130 | D | $67.81 · 2013-11-15 to 2023-05-14 | 15,000 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 6 | Derivative | Stock Option (Right to buy Common Stock) | 2023-03-13 | M | D | 8,000 | $0.00 | 149,130 | D | $67.81 · 2013-11-15 to 2023-05-14 | 8,000 Common Stock | (F2) Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |